SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-C - Written communication relating to an issuer or third party:
SEC Accession No. 0001193125-11-298770
Filing Date
2011-11-07
Accepted
2011-11-07 08:43:23
Documents
5

Document Format Files

Seq Description Document Type Size
1 TENDER OFFER STATEMENT d253271dsctoc.htm SC TO-C 19517
2 PRESS RELEASE d253271dex991.htm EX-99.1 18596
3 INTERNAL COMMUNICATIONS MATERIALS d253271dex992.htm EX-99.2 9230
4 GRAPHIC g253271ex99_1001.jpg GRAPHIC 10212
5 GRAPHIC g253271ex99_2001.jpg GRAPHIC 146601
  Complete submission text file 0001193125-11-298770.txt   265548
Mailing Address ONE AMGEN CENTER DRIVE MAIL STOP 24-1-B THOUSAND OAKS CA 91320-1799
Business Address ONE AMGEN CENTER DRIVE MAIL STOP 24-1-B THOUSAND OAKS CA 91320-1799 (805)313-1762
AMGEN INC (Filed by) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-C
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address ONE AMGEN CENTER DRIVE MAIL STOP 24-1-B THOUSAND OAKS CA 91320-1799
Business Address ONE AMGEN CENTER DRIVE MAIL STOP 24-1-B THOUSAND OAKS CA 91320-1799 (805)313-1762
AMGEN INC (Subject) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-C | Act: 34 | File No.: 005-34640 | Film No.: 111182944
SIC: 2836 Biological Products, (No Diagnostic Substances)